Metabolomics Market by Product and Service (Metabolomics Instruments, and Metabolomics Bioinformatics Tools & Services), Application (Biomarkers Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Others), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism), and End-use Industry (Contract Research Organizations, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies), and Region, Global Trends and Forecast From 2023 To 2030

Published on: Nov 2023
From:USD $3499.00
Number Of Pages:144

Please Choose License Type

Single User

Team User

Corporate License

Request a Sample

INTERESTED IN THIS RESEARCH?

Contact our analysts for inquiries, samples, and expert insights.

Market Size	CAGR	Dominating Region
USD 7.13 billion by 2030	14%	North America

Market by Product and Service	Market by Application	Market by Indication
Metabolomics instruments Metabolomics Bio information Tools & Services	Biomarkers Discovery Drug Discovery Toxicology Testing Nutrigenomics Functional Genomics Personalized Medicine Others	Cancer Cardiovascular Disorder Neurological Disorders Inborn Errors of Metabolism

4.9/5 - (10 votes)

Metabolomics Market Overview

The global metabolomics market is expected to grow at 14% CAGR from 2023 to 2030. It is expected to reach above USD 7.13 billion by 2030 from USD 2.9 billion in 2023.

Metabolomics is a rapidly expanding subject within the life sciences and healthcare industries that focuses on the thorough investigation of metabolites in biological systems. Metabolomics is a subset of omics science that studies tiny chemicals called metabolites that are involved in cellular functions and metabolic pathways. Sugars, amino acids, lipids, organic acids, and other tiny molecules are examples of metabolites. Metabolomics has gained prominence in a variety of fields, including drug discovery and development, personalized medicine, biomarker identification, agricultural research, and environmental monitoring. Metabolomics can give useful insights into the underlying physiological and biochemical processes occurring in an organism by evaluating the metabolic profile of a biological sample.

Metabolomics plays a critical role in the development of personalized medicine by offering insights into individual differences in medication response, disease susceptibility, and treatment results. Analytical technology advancements: The development of improved analytical technologies such as mass spectrometry, nuclear magnetic resonance (NMR) spectroscopy, and chromatography has enabled high-throughput and accurate metabolite analysis, propelling the metabolomics industry forward.

Metabolomics Market | Exactitude Consultancy

Metabolomics platforms and devices, metabolomics software and data analysis tools, metabolite databases, and metabolomics services (such as sample preparation, metabolite profiling, and data interpretation) are all part of the market. Companies may also provide metabolomics-based research services or build specialized metabolomics solutions for specific uses. Metabolomics is the study of metabolites using diverse analytical techniques such as spectroscopy, chromatography, and multivariate analysis. Metabolites are intimately connected to an organism’s phenotype and may be employed for a variety of applications including significant equivalence testing, phenotyping of genetically modified plants, gene function identification, and biotic-abiotic stress response study.

Metabolomics is the study of biochemical processes that comprise metabolomes, which are intermediates and byproducts of metabolic activity. It entails determining metabolites using different metabolomics analysis methods such as spectroscopy, multivariant analysis, and chromatography. Metabolites are linked to an organism’s phenotype. They have a wide range of uses, including phenotyping of genetically modified plants, significant equivalence testing, gene function identification, and biotic-abiotic stress response study. It also makes it easier for researchers and scientists to compute physiological impacts while viewing the unfavorable effects of medications on an organism.

ATTRIBUTE	DETAILS
Study period	2020-2030
Base year	2022
Estimated year	2023
Forecasted year	2023-2030
Historical period	2019-2021
Unit	Value (USD Billion)
Segmentation	By Packaging type, Material, End-user industry, and region.
By Product and Service	Folding Boxes Metabolomics instruments Metabolomics Bio information Tools & Services
By Application	Biomarkers Discovery Drug Discovery Toxicology Testing Nutrigenomics Functional Genomics Personalized Medicine Others
By Indication	Cancer Cardiovascular Disorder Neurological Disorders Inborn Errors of Metabolism
By End-user industry	Contract Research Organization Academic and Research Institutes Pharmaceutical and Biotechnology Companies
By Region	North America Asia Pacific Europe South America Middle East Asia & Africa

Segment Analysis: Metabolomics Market

Furthermore, metabolomics has the potential to identify a high number of metabolites from a fluid or tissue sample in a single step and may yield huge volumes, which leads to an increase in demand for metabolomics and hence drives market expansion.

The most popular analytical methods used for metabolomics applications are nuclear magnetic resonance spectroscopy (NMR) and mass spectrometry (MS). A wide range of approaches within these two technical disciplines is now being developed to deal with the complex samples evaluated in metabolomics investigations. Due to its exceptional identification skills, metabolomics has enormous promise in illness diagnosis, prognosis, and treatment development.

The high cost of metabolomic devices and the shortage of personnel are both restraints for the metabolomics market. Top-tier analytical and separations devices are prohibitively expensive due to the high cost of raw materials and production costs. For example, the cost of mass spectrometry and high-performance liquid chromatography devices ranges between a million and a thousand dollars per device. The high cost of metabolomics instruments can stifle market growth in developing and underdeveloped areas as even commercial buyers are unable to purchase such equipment, limiting the applications of metabolomics technology.

Smart pricing is expected to boost the customer base, favorably affecting the growth of the global metabolomics market. The metabolomic market has enormous potential in illness diagnostics. Early diagnosis of chronic illnesses helps healthcare practitioners to plan successful disease treatment, increasing patient longevity and assisting in the ultimate removal of the disease from the patient’s biological system.

Based on end user, pharmaceutical and biotechnology companies segment dominating in the metabolomics market. The pharmaceutical and biotechnology industry is the dominating industry in the metabolomics market, accounting for over 50% of the global market share. This is due to the increasing use of metabolomics in drug discovery and development, as well as in clinical research.

Market Players: Metabolomics Market

The metabolomics market’s key players include Waters Corporation, Merck KGaA, GE Healthcare, Hitachi High- Technologies Corporation, Human metabolome Technologies, Inc, LECO Corporation, metabolon Inc, Bio-Rad Laboratories, Agilent Technologies, Shimadzu Corporation, Thermo Fisher Scientific, Danaher Corporation, Bruker Corporation, PerkinElmer, Scion Instruments, DANI instruments S.P.A, GL Sciences, SRI Instruments, Kore technology Ltd, JASCO Ins, among others.

For corporate expansion, these key leaders are implementing strategic formulations such as new product development and commercialization, commercial expansion, and distribution agreements. Moreover, these participants are substantially spending on product development, which is fueling revenue generation.

Recent Developments:

May 2023 – Bio-Rad and AD Instruments collaborate to integrate Bio-Rad Explorer classroom laboratory activities with Lt, the Award-Winning Online Learning Platform. For an unrivaled life science classroom experience, the new lessons combine Bio-Rad Explorer kit activities with AD Instruments’ cloud-based active-learning platform, Lt.
April 2023 – Hitachi High-Tech Announces New Semiconductor Manufacturing Equipment Production Facility in Kasado Area. A carbon-neutral plant that will quadruple the etching system manufacturing capacity. To meet the ever-increasing demand for semiconductor manufacturing equipment, the new facility will treble production capacity with digitalized and automated production lines. The facility will also be carbon-neutral, in keeping with Hitachi High-Tech’s goal of achieving carbon neutrality at all of its business locations (factories and offices) by FY2027 in order to build a decarbonized society.
February 2023 – One of the company’s primary initiatives toward attaining the 2024 Mid-Term Management Plan was the reorganization of its activities to boost skills in tackling social infrastructure concerns. The firm focused on the OT business, which provided solutions using measurement, control, and digital technologies, and the IS business, which specialized in railway inspection equipment. Hitachi High-Tech Solutions aimed to become a technology and solutions firm that addressed social infrastructure concerns across diverse industrial sectors by using sensing and control capabilities.

Who Should Buy? Or Key stakeholders

Investors
Food and Beverage industry

Medical Technology Companies
Healthcare and personal care firms
Research Organizations
Regulatory Authorities
Institutional & retail players
Others

Regional Analysis: Metabolomics Market

The metabolomics market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN, and Rest of APAC
Europe: includes the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe
South America: includes Brazil, Argentina, and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and the Rest of MEA

North America, the metabolomics market is dominated by North America, notably the United States. The region offers a well-established healthcare infrastructure, a strong emphasis on R&D, and a favorable regulatory environment. The expansion of the metabolomics market in this area is supported by major academic and research organizations, as well as pharmaceutical and biotechnology corporations.

Europe is another important area in the metabolomics industry. Countries with a prominent presence in metabolomics research and applications include the United Kingdom, Germany, France, and the Netherlands. The region boasts a strong academic and research network, as well as an advantageous financing climate for scientific research. Collaborations between academia, business, and government institutions are propelling the European metabolomics sector forward.

The Asia Pacific region’s metabolomics market is expanding rapidly. China, Japan, and South Korea are all substantially investing in metabolomics research and infrastructure development. The region’s need for metabolomics solutions is being driven by the increased prevalence of chronic illnesses, rising healthcare spending, and a growing emphasis on customized therapy.

The Middle East and Africa metabolomics market is still in its early stages, but it has tremendous development potential. Metabolomics research and applications are gaining popularity in countries such as South Africa, Saudi Arabia, and the United Arab Emirates. The existence of prominent research institutes, the expansion of healthcare infrastructure, and increased spending on scientific research are all factors driving market growth in this area.

Key Market Segments: Metabolomics Market

Metabolomics Market by Product and Service, 2020-2030, (USD Billion)

Metabolomics instruments
Metabolomics Bio information Tools & Services

Metabolomics Market by Application, 2020-2030, (USD Billion)

Biomarkers Discovery
Drug Discovery
Toxicology Testing
Nutrigenomics
Functional Genomics
Personalized Medicine
Others

Metabolomics Market by Indication, 2020-2030, (USD Billion)

Cancer
Cardiovascular Disorder
Neurological Disorders
Inborn Errors of Metabolism

Metabolomics Market by End-User Industry, 2020-2030, (USD Billion)

Contract Research Organization
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies

Metabolomics Market by Region, 2020-2030, (USD Billion)

North America
Asia Pacific
Europe
South America
Middle East and Africa

Important Countries in All Regions Are Covered.

Exactitude Consultancy Services Key Objectives

Increasing sales and market share
Developing new technology
Improving profitability
Entering new markets
Enhancing brand reputation

Key Question Answered

What is the expected growth rate of the metabolomics market over the next 7 years?
What are the end-user industries driving demand for the market and what is their outlook?
What are the opportunities for growth in emerging markets such as Asia-Pacific, the Middle East, and Africa?
How is the economic environment affecting the metabolomics market, including factors such as interest rates, inflation, and exchange rates?
What is the expected impact of government policies and regulations on the metabolomics market?
What are the key drivers of growth in the metabolomics market?
Who are the market’s major players, and what is their market share?
What are the metabolomics market’s distribution channels and supply chain dynamics?
What are the technological advancements and innovations in the metabolomics market and their impact on product development and growth?
What are the regulatory considerations and their impact on the market?
What are the challenges faced by players in the metabolomics market and how are they addressing these challenges?
What are the opportunities for growth and expansion in the metabolomics market?
What are the market’s product offerings/ service offerings and specifications of leading players?
What is the pricing trend of metabolomics in the market and what is the impact of raw material prices on the price trend?

INTRODUCTION
1. MARKET DEFINITION
2. MARKET SEGMENTATION
3. RESEARCH TIMELINES
4. ASSUMPTIONS AND LIMITATIONS
RESEARCH METHODOLOGY
1. DATA MINING
  1. SECONDARY RESEARCH
  2. PRIMARY RESEARCH
  3. SUBJECT-MATTER EXPERTS’ ADVICE
2. QUALITY CHECKS
  1. FINAL REVIEW
3. DATA TRIANGULATION
  1. BOTTOM-UP APPROACH
  2. TOP-DOWN APPROACH
  3. RESEARCH FLOW
4. DATA SOURCES
EXECUTIVE SUMMARY
MARKET OVERVIEW
1. GLOBAL METABOLOMICS MARKET OUTLOOK
  1. MARKET DRIVERS
  2. MARKET RESTRAINTS
  3. MARKET OPPORTUNITIES
2. IMPACT OF COVID-19 ON THE METABOLOMICS MARKET
3. PORTER’S FIVE FORCES MODEL
  1. THREAT FROM NEW ENTRANTS
  2. THREAT FROM SUBSTITUTES
  3. BARGAINING POWER OF SUPPLIERS
  4. BARGAINING POWER OF CUSTOMERS
  5. DEGREE OF COMPETITION
4. INDUSTRY VALUE CHAIN ANALYSIS
GLOBAL METABOLOMICS MARKET BY INDICATION AND SERVICE, 2020-2030, (USD BILLION)
1. METABOLOMICS INSTRUMENTS
2. METABOLOMICS BIO INFORMATION TOOLS & SERVICES
GLOBAL METABOLOMICS MARKET BY APPLICATION, 2020-2030, (USD BILLION)
1. BIOMARKERS DISCOVERY
2. DRUG DISCOVERY
3. TOXICOLOGY TESTING
4. NUTRIGENOMICS
5. FUNCTIONAL GENOMICS
6. PERSONALIZED MEDICINE
7. OTHERS
GLOBAL METABOLOMICS MARKET BY INDICATION, 2020-2030, (USD BILLION)
1. CANCER
2. CARDIOVASCULAR DISORDER
3. NEUROLOGICAL DISORDERS
4. INBORN ERRORS OF METABOLISM
GLOBAL METABOLOMICS MARKET BY END-USER INDUSTRY, 2020-2030, (USD BILLION)
1. CONTRACT RESEARCH ORGANIZATION
2. ACADEMIC AND RESEARCH INSTITUTES
3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
GLOBAL METABOLOMICS MARKET BY REGION, 2022-2029, (USD BILLION)
1. NORTH AMERICA
  1. US
  2. CANADA
  3. MEXICO
2. SOUTH AMERICA
  1. BRAZIL
  2. ARGENTINA
  3. COLOMBIA
  4. REST OF SOUTH AMERICA
3. EUROPE
  1. GERMANY
  2. UK
  3. FRANCE
  4. ITALY
  5. SPAIN
  6. RUSSIA
  7. REST OF EUROPE
4. ASIA PACIFIC
  1. INDIA
  2. CHINA
  3. JAPAN
  4. SOUTH KOREA
  5. AUSTRALIA
  6. SOUTH-EAST ASIA
  7. REST OF ASIA PACIFIC
5. MIDDLE EAST AND AFRICA
  1. UAE
  2. SAUDI ARABIA
  3. SOUTH AFRICA
  4. REST OF MIDDLE EAST AND AFRICA

COMPANY PROFILES*(BUSINESS OVERVIEW, COMPANY SNAPSHOT, INDICATIONS OFFERED, RECENT DEVELOPMENTS)
1. WATERS CORPORATION
2. MERCK KGAA
3. GE HEALTHCARE
4. HITACHI HIGH- TECHNOLOGIES CORPORATION
5. HUMAN METABOLOME TECHNOLOGIES, INC
6. LECO CORPORATION
7. METABOLON INC
8. BIO-RAD LABORATORIES
9. AGILENT TECHNOLOGIES
10. SHIMADZU CORPORATION
11. THERMO FISHER SCIENTIFIC
12. DANAHER CORPORATION
13. BRUKER CORPORATION
14. PERKINELMER
15. SCION INSTRUMENTS
16. DANI INSTRUMENTS S.P.A
17. GL SCIENCES, SRI INSTRUMENTS
18. KORE TECHNOLOGY LTD
19. JASCO INS,*THE COMPANY LIST IS INDICATIVE

LIST OF TABLES

TABLE 1 GLOBAL METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 2 GLOBAL METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 3 GLOBAL METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 4 GLOBAL METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 5 GLOBAL METABOLOMICS MARKET BY REGION (USD BILLION) 2020-2030

TABLE 6 NORTH AMERICA METABOLOMICS MARKET BY COUNTRY (USD BILLION) 2020-2030

TABLE 7 NORTH AMERICA METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 8 NORTH AMERICA METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 9 NORTH AMERICA METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 10 NORTH AMERICA METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 11 US METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 12 US METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 13 US METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 14 US METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 15 CANADA METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 16 CANADA METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 17 CANADA METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 18 CANADA METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 19 MEXICO METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 20 MEXICO METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 21 MEXICO METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 22 MEXICO METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 23 SOUTH AMERICA METABOLOMICS MARKET BY COUNTRY (USD BILLION) 2020-2030

TABLE 24 SOUTH AMERICA METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 25 SOUTH AMERICA METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 26 SOUTH AMERICA METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 27 SOUTH AMERICA METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 28 BRAZIL METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 29 BRAZIL METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 30 BRAZIL METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 31 BRAZIL METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 32 ARGENTINA METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 33 ARGENTINA METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 34 ARGENTINA METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 35 ARGENTINA METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 36 COLOMBIA METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 37 COLOMBIA METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 38 COLOMBIA METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 39 COLOMBIA METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 40 REST OF SOUTH AMERICA METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 41 REST OF SOUTH AMERICA METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 42 REST OF SOUTH AMERICA METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 43 REST OF SOUTH AMERICA METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 44 ASIA-PACIFIC METABOLOMICS MARKET BY COUNTRY (USD BILLION) 2020-2030

TABLE 45 ASIA-PACIFIC METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 46 ASIA-PACIFIC METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 47 ASIA-PACIFIC METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 48 ASIA-PACIFIC METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 49 INDIA METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 50 INDIA METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 51 INDIA METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 52 INDIA METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 53 CHINA METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 54 CHINA METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 55 CHINA METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 56 CHINA METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 57 JAPAN METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 58 JAPAN METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 59 JAPAN METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 60 JAPAN METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 61 SOUTH KOREA METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 62 SOUTH KOREA METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 63 SOUTH KOREA METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 64 SOUTH KOREA METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 65 AUSTRALIA METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 66 AUSTRALIA METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 67 AUSTRALIA METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 68 AUSTRALIA METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 69 SOUTH-EAST ASIA METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 70 SOUTH-EAST ASIA METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 71 SOUTH-EAST ASIA METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 72 SOUTH-EAST ASIA METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 73 REST OF ASIA PACIFIC METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 74 REST OF ASIA PACIFIC METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 75 REST OF ASIA PACIFIC METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 76 REST OF ASIA PACIFIC METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 77 EUROPE METABOLOMICS MARKET BY COUNTRY (USD BILLION) 2020-2030

TABLE 78 EUROPE METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 79 EUROPE METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 80 EUROPE METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 81 EUROPE METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 82 GERMANY METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 83 GERMANY METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 84 GERMANY METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 85 GERMANY METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 86 UK METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 87 UK METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 88 UK METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 89 UK METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 90 FRANCE METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 91 FRANCE METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 92 FRANCE METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 93 FRANCE METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 94 ITALY METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 95 ITALY METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 96 ITALY METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 97 ITALY METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 98 SPAIN METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 99 SPAIN METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 100 SPAIN METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 101 SPAIN METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 102 RUSSIA METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 103 RUSSIA METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 104 RUSSIA METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 105 RUSSIA METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 106 REST OF EUROPE METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 107 REST OF EUROPE METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 108 REST OF EUROPE METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 109 REST OF EUROPE METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 110 MIDDLE EAST AND AFRICA METABOLOMICS MARKET BY COUNTRY (USD BILLION) 2020-2030

TABLE 111 MIDDLE EAST AND AFRICA METABOLOMICS MARKET BY CIRCULATING BIOMARKERS (USD BILLION) 2020-2030

TABLE 112 MIDDLE EAST AND AFRICA METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 113 MIDDLE EAST AND AFRICA METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 114 MIDDLE EAST AND AFRICA METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 115 UAE METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 116 UAE METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 117 UAE METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 118 UAE METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 119 SAUDI ARABIA METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 120 SAUDI ARABIA METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 121 SAUDI ARABIA METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 122 SAUDI ARABIA METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 123 SOUTH AFRICA METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 124 SOUTH AFRICA METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 125 SOUTH AFRICA METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 126 SOUTH AFRICA METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

TABLE 127 REST OF MIDDLE EAST AND AFRICA METABOLOMICS MARKET BY PRODUCTS AND SERVICE (USD BILLION) 2020-2030

TABLE 128 REST OF MIDDLE EAST AND AFRICA METABOLOMICS MARKET BY APPLICATION (USD BILLION) 2020-2030

TABLE 129 REST OF MIDDLE EAST AND AFRICA METABOLOMICS MARKET BY INDICATION (USD BILLION) 2020-2030

TABLE 130 REST OF MIDDLE EAST AND AFRICA METABOLOMICS MARKET BY END USER (USD BILLION) 2020-2030

LIST OF FIGURES

FIGURE 1 MARKET DYNAMICS

FIGURE 2 MARKET SEGMENTATION

FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4 DATA TRIANGULATION

FIGURE 5 BOTTOM-UP APPROACH

FIGURE 6 TOP-DOWN APPROACH

FIGURE 7 RESEARCH FLOW

FIGURE 8 GLOBAL METABOLOMICS MARKET BY PRODUCTS AND SERVICE, USD BILLION, 2020-2030

FIGURE 9 GLOBAL METABOLOMICS MARKET BY APPLICATION, USD BILLION, 2020-2030

FIGURE 10 GLOBAL METABOLOMICS MARKET BY INDICATION, USD BILLION, 2020-2030

FIGURE 11 GLOBAL METABOLOMICS MARKET BY END USER, USD BILLION, 2020-2030

FIGURE 12 GLOBAL METABOLOMICS MARKET BY REGION, USD BILLION, 2020-2030

FIGURE 13 PORTER’S FIVE FORCES MODEL

FIGURE 14 GLOBAL METABOLOMICS MARKET BY PRODUCTS AND SERVICE, USD BILLION,2022

FIGURE 15 GLOBAL METABOLOMICS MARKET BY APPLICATION, USD BILLION2022

FIGURE 16 GLOBAL METABOLOMICS MARKET BY INDICATION, USD BILLION 2022

FIGURE 17 GLOBAL METABOLOMICS MARKET BY END USER, USD BILLION 2022

FIGURE 18 METABOLOMICS MARKET BY REGION, USD BILLION 2022

FIGURE 19 MARKET SHARE ANALYSIS

FIGURE 20 WATERS CORPORATION: COMPANY SNAPSHOT

FIGURE 21 MERCK KGAA: COMPANY SNAPSHOT

FIGURE 22 GE HEALTHCARE: COMPANY SNAPSHOT

FIGURE 23 HITACHI HIGH-TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT

FIGURE 24 HUMAN METABOLOMICS TECHNOLOGIES INC: COMPANY SNAPSHOT

FIGURE 25 LECO CORPORATION: COMPANY SNAPSHOT

FIGURE 26 METABOLON INC: COMPANY SNAPSHOT

FIGURE 27 BIO-RAD CORPORATION: COMPANY SNAPSHOT

FIGURE 28 KORE TECHNOLOGIES: COMPANY SNAPSHOT

• What is the worth of the global metabolomics market?

The global metabolomics market is expected to grow at 14% CAGR from 2023 to 2030. It is expected to reach above USD 7.13 billion by 2030 from USD 2.9 billion in 2023.

• What are some of the market's driving forces?

• Which are the top companies to hold the market share in the metabolomics market?

• What is the leading application of the metabolomics market?

Metabolomics is finding applications in a variety of industries, including pharmaceuticals, biotechnology, food and beverage, agriculture, and environmental sciences, which is extending the market prospects for metabolomics research and analysis. Increasing research funding: Governments, academic institutions, and corporate entities are all investing heavily in metabolomics research, giving financial support for progress in this subject.

• Which is the largest regional market for metabolomics market?

The Markets largest share is in the North American region.

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Complete pre and post sales
support.

Safe & Secure

Complete secure payment
process.

INTERESTED IN THIS RESEARCH?

REPORT OUTLOOK

SCOPE OF THE REPORT

Metabolomics Market Overview

Segment Analysis: Metabolomics Market

Market Players: Metabolomics Market

Who Should Buy? Or Key stakeholders

Regional Analysis: Metabolomics Market

Key Market Segments: Metabolomics Market

Exactitude Consultancy Services Key Objectives

Key Question Answered

Table of Content

LIST OF TABLES

LIST OF FIGURES

FAQ

DOWNLOAD FREE SAMPLE REPORT

Inquire for Discount

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure

6 Elmore Road, Luton, Bedfordshire LU20QB, UK

Plot No. 39, SR, 10-16, NDA Pashan Rd, Bavdhan, Pune, Maharashtra 411021

Subscribe our newsletter

INTERESTED IN THIS RESEARCH?

REPORT OUTLOOK

SCOPE OF THE REPORT

Metabolomics Market Overview

Segment Analysis: Metabolomics Market

Market Players: Metabolomics Market

Who Should Buy? Or Key stakeholders

Regional Analysis: Metabolomics Market

Key Market Segments: Metabolomics Market

Exactitude Consultancy Services Key Objectives

Key Question Answered

Table of Content

LIST OF TABLES

LIST OF FIGURES

FAQ

Related Reports

DOWNLOAD FREE SAMPLE REPORT

Inquire for Discount

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure